Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
All Posts By
admin
APhA Annual Conference 2021: Don’t ‘Just Say No’: Preventing Diversion and Addressing Medical Needs
February 19, 2021
ED Visits for Opioid Poisonings Up 29%
News
February 10, 2021
Biden To Reverse Trump X Waiver Policy
News
January 25, 2021
Federal Gov’t Expands Access to Buprenorphine for OUD
News
January 14, 2021
Alternative Therapies in Pain Management: Evidence-Based Approaches – New York Conference
November 12, 2020
DEA Expanding Surveillance of Prescription Drug Data
News
November 11, 2020
DEA Supercharges Patient, Prescriber, Pharmacist Surveillance
News
November 9, 2020
Alternative Therapies in Pain Management: Evidence-Based Approaches – Tennessee Conference
November 5, 2020
Stigma Against OUD Medications Persists
Report
October 20, 2020
Prepare to E-Prescribe Controlled Drugs for Medicare Participants
News
July 28, 2020
FDA Recommends Discussing Naloxone When Prescribing Opioids
News
July 23, 2020
Drug Overdose Deaths Up 4.6% in 2019
News
July 16, 2020
More
« Previous
